- Public Comps
- Steep Hill
Steep Hill Valuation Multiples
Discover Steep Hill's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like SOL Global Investments, Agrios Global Holdings, Grow Solutions Holdings, The Cannabist Company and more.
Steep Hill Overview
About Steep Hill
Steep Hill Inc is a science and technology health and wellness company focused on the hemp markets inclusive of plant-based, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) verticals. Currently the company, through its subsidiaries holds three industrial hemp licences for the purposes of supplying the market with medicinal and wellness cannabidiol and other cannabinoid-based products.
Founded
2018
HQ

Employees
7
Website
Financials (FY)
Market Cap
$646K
Valuation Multiples
Start free trialSteep Hill Stock Performance
Steep Hill has current market cap of $646K.
Steep Hill's stock price is $0.24.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| $646K | 0.0% | - | - | - | - |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSteep Hill Valuation Multiples
Steep Hill Financial Valuation Multiples
As of August 14, 2026, Steep Hill has market cap of $646K.
| LTM | Last FY | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Steep Hill Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Steep Hill Competitors
Steep Hill competitors include SOL Global Investments, Agrios Global Holdings, Grow Solutions Holdings, The Cannabist Company, RAMM Pharma, Ayr Wellness, Pharmadrug, Indoor Harvest, Xebra Brands and Aion Therapeutic.
Most Steep Hill public comparables operate across Cannabis, CannaTech and ViceTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| (0.1x) | - | - | - | |||
| - | - | - | - | |||
| - | - | - | - | |||
| 0.9x | - | 14.9x | - | |||
| 0.3x | - | (0.1x) | - | |||
| 1.3x | - | (3.9x) | - | |||
| - | - | (35.7x) | - | |||
| - | - | (0.4x) | - | |||
This data is available for Pro users. Sign up to see all Steep Hill competitors and their valuation data. Start Free Trial | ||||||
Steep Hill VC Funding History
Before going public, Steep Hill raised $20M in total equity funding, across 8 rounds.
Steep Hill Funding Rounds
Acquisitions by Steep Hill
Steep Hill has acquired 2 companies to date.
Last acquisition by Steep Hill was on August 6th 2026. Steep Hill acquired Alchemy Analytics for undisclosed valuation.
Latest Acquisitions by Steep Hill
| Description | Alchemy Analytics is a testing laboratory focused on quality verification for medical cannabis products. | LIR Life Sciences is a biopharmaceutical company developing treatments for obesity and metabolic disorders while expanding into additional therapy areas with next-generation drug candidates. |
| HQ Country | - | |
| HQ City | - | Vancouver |
| Deal Date | 6 Aug 2026 | 12 Feb 2025 |
| Valuation | undisclosed | undisclosed |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Steep Hill acquisitions and their M&A valuation multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Steep Hill
| When was Steep Hill founded? | Steep Hill was founded in 2018. |
| Where is Steep Hill headquartered? | Steep Hill is headquartered in Canada. |
| How many employees does Steep Hill have? | As of today, Steep Hill has over 7 employees. |
| Is Steep Hill publicly listed? | Yes, Steep Hill is a public company listed on Canadian Securities Exchange. |
| What is the stock symbol of Steep Hill? | Steep Hill trades under STPH ticker. |
| When did Steep Hill go public? | Steep Hill went public in 2020. |
| Who are competitors of Steep Hill? | Steep Hill main competitors include SOL Global Investments, Agrios Global Holdings, Grow Solutions Holdings, The Cannabist Company, RAMM Pharma, Ayr Wellness, Pharmadrug, Indoor Harvest, Xebra Brands, Aion Therapeutic. |
| What is the current market cap of Steep Hill? | Steep Hill's current market cap is $646K. |
| Is Steep Hill profitable? | No, Steep Hill is not profitable. |
| How many companies Steep Hill has acquired to date? | As of August 2026, Steep Hill has acquired 2 companies. |
| What was the largest acquisition by Steep Hill? | None of the M&A deals Steep Hill has completed have disclosed valuations. |
| What companies Steep Hill acquired? | Steep Hill acquired LIR life Sciences and Alchemy Analytics. |
| In how many companies Steep Hill has invested to date? | Steep Hill hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Steep Hill
Lists including Steep Hill
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.





